Sulabha Ranganathan

1.4k citations
30 papers · 1.2k indexed · h-index 18
Topics
Cancer Treatment and Pharmacology (6 papers)Microtubule and mitosis dynamics (5 papers)Genomics, phytochemicals, and oxidative stress (4 papers)
Journals
Journal of Biological ChemistryJournal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations
United StatesFranceItaly

In The Last Decade

Sulabha Ranganathan

30 papers receiving 1.2k citations

Peers

Sulabha Ranganathan
Comparison fields: 5 of 99
  • Molecular Biology 678
  • Oncology 443
  • Cell Biology 304
  • Cancer Research 160
  • Clinical Biochemistry 155
Replace Francesca Grespi with:
Francesca Grespi Italy
Aruna Basu United States
Maria M. Simile Italy
Angelina V. Vaseva United States
Gabriel Pons Spain
Zhirong Shen China
Xiongxiong Liu China
Sejal Vyas United States
Ming-Ming Tsai Taiwan
Sushant K. Kachhap United States
Sulabha Ranganathan relative to Francesca Grespi Italy Francesca Grespi's profile →
Citations per field
00.5×1.7×
Francesca Grespi · 1×
Citations per year

Countries citing papers authored by Sulabha Ranganathan

Since Specialization
Citations

This map shows the geographic impact of Sulabha Ranganathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sulabha Ranganathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sulabha Ranganathan more than expected).

Fields of papers citing papers by Sulabha Ranganathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sulabha Ranganathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sulabha Ranganathan. The network helps show where Sulabha Ranganathan may publish in the future.

Co-authorship network of co-authors of Sulabha Ranganathan

This figure shows the co-authorship network connecting the top 25 collaborators of Sulabha Ranganathan. A scholar is included among the top collaborators of Sulabha Ranganathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sulabha Ranganathan. Sulabha Ranganathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 11
2 50
3 3
4 28
5
Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.
76
6 57
7 42
8 194
9 36
10 56
11 31
12 66
13 59
14 23
15 13
16 15
17 2
18 10
19 23
20 8

About Sulabha Ranganathan

Sulabha Ranganathan is a scholar working on Clinical Biochemistry, Oncology and Obstetrics and Gynecology, having authored 30 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Microtubule and mitosis dynamics (5 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). The work is most often cited by research in Clinical Biochemistry (155 citations), Cell Biology (304 citations) and Oncology (443 citations). Sulabha Ranganathan has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Kenneth D. Tew, G. R. Hudes, Eileen S. Walsh, Ronald D. Hood, Gary R. Hudes, Andrew K. Godwin, Christopher A. Benetatos, Paul J. Ciaccio, Louis M. Weiner and Björn Dahllöf. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026